What is Castle Biosciences's change in AR?

Castle Biosciences (CSTL) reported change in AR of -$1.08M in Q1 2026.

How has Castle Biosciences's change in AR changed year-over-year?

Castle Biosciences's change in AR decreased by 120.6% year-over-year, from $5.22M to -$1.08M.

What is the long-term trend for Castle Biosciences's change in AR?

Over 3 years (2022 to 2025), Castle Biosciences's change in AR has grown at a 3.4% compound annual growth rate (CAGR), from $6.22M to -$6.88M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Castle Biosciences CSTL Change in AR

Change in AR at other companies

Labcorp HoldingsLH

$187.9M+10.0%

VeracyteVCYT

$5.57M-21.1%

Personalis, Inc.PSNL

-$3.18M-212%

NeoGenomicsNEO

$8.18M+1,125%

Fulgent Genetics, Inc.FLGT

-$16.43M-463%

GeneDx HoldingsWGS

$2.56M-70.1%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's change in AR?: Castle Biosciences (CSTL) reported change in AR of -$1.08M in Q1 2026.
How has Castle Biosciences's change in AR changed year-over-year?: Castle Biosciences's change in AR decreased by 120.6% year-over-year, from $5.22M to -$1.08M.
What is the long-term trend for Castle Biosciences's change in AR?: Over 3 years (2022 to 2025), Castle Biosciences's change in AR has grown at a 3.4% compound annual growth rate (CAGR), from $6.22M to -$6.88M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.